As the leading supplier of basic research money inĀ the US, the National Institutes ofĀ Health likes toĀ get credit for its work. But not too much credit.
For the second time inĀ three years, the NIHās top official inĀ charge ofĀ research grants has pleaded with scientists toĀ stop crediting the agency inĀ their journal publications ifĀ the NIH wasĀ not actually involved inĀ supporting their work.
The practice, said Michael Lauer, the NIHās deputy director in charge of extramural research, might ādistort the true effect of NIH fundingā. Among other things, Dr Lauer said, that made it harder for the NIH to prove its value to Congress and taxpayers.
What might seem a fairly straightforward part of writing a research article, Dr Lauer acknowledged, could actually become fairly complicated. Scientists often received financial support from a number of sources, and it was not always easy to decide how to allocate credit.
51³Ō¹Ļ
āIn some cases,ā he told the research community in aĀ , āit may be difficult to identify which awards directly support a specific activity, especially in situations such as for large programme projects with multiple components.ā
The NIH required researchers to credit the agency on articles that derive from its funding, Dr Lauer said ā but, just as importantly, āovercitationā was not allowed because the information was critical to accountability processes.
51³Ō¹Ļ
Also, Dr Lauer said, faulty listings of grant support greatly complicated the job for researchers who volunteered to review NIH grant applications, because they needed such information to assess productivity levels.
Paul Fuchs, a professor of otolaryngology at Johns Hopkins University who has served on multiple NIH grant review panels, said he understood the NIHās concern, but also saw ways the agency could be more helpful with the complexity of the citation challenge.
If researchers listed all their funders and collaborators in their publications, Professor Fuchs said, that could greatly complicate the job of determining a fair allocation of credit. But if researchers gave a shorter list, that could short-change smaller labs that contributed to scientific findings, he said.
Professor Fuchs added that, even as a volunteer reviewer, he took the time to try to figure out who really contributed to a research project when assessing which applications were worthy of more support. That process āat least gives me a way of trying to evaluate how a big powerful lab with lots of collaborations may in fact really stack up to a small lab without collaborationsā, he said.
51³Ō¹Ļ
The NIH did not collect data on the frequency of overcitation problems, an agency spokesperson said. But in some cases, they added, the mistake was obvious, such as when a published study on research involving human participants gave credit to a grant that did not allow for human participant research.
Other mistakes appeared to involve researchers trying too hard to head off any perception of hiding financial conflicts of interest, the spokesperson said.
The NIH did not have any indication, they added, that the practice of overcitation could be related to the China Initiative ā the Trump-era campaign, which the NIH assisted, to identify and prosecute scientists of Chinese descent, often on the legal grounds that they took money from both US and Chinese sources without fully disclosing it.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to °Õ±į·”ās university and college rankings analysis
Already registered or a current subscriber?








